Form 4: Kindly MD Director Granted 112,781 Restricted Stock Units

Kindly MD, Inc. Director Eric Stanton Weiss was granted 112,781 restricted stock units, vesting on August 15, 2026.

Summary

• Eric Stanton Weiss, a Director of Kindly MD, Inc. (NAKA), acquired 112,781 shares of Common Stock.
• These shares are Restricted Stock Units (RSUs) granted on September 22, 2025.
• The RSUs will vest on August 15, 2026, contingent on Mr. Weiss's continued service on the board of directors.
• The acquisition price for these RSUs was $0, which is typical for such grants.

Sentiment

Score: 6

Explanation: The filing indicates a standard equity compensation grant to a director, which is a neutral to slightly positive event. It suggests continued commitment from a board member and aligns interests with shareholders, but does not provide new financial performance data.

Positives

• The grant of Restricted Stock Units to Director Eric Stanton Weiss aligns his interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• The vesting schedule through August 15, 2026, incentivizes Mr. Weiss's continued service and commitment to the company's long-term success.

Risks

• The value of the RSUs is subject to the future market price of Kindly MD, Inc. common stock, meaning the actual realized value could be lower than the grant date value if the stock price declines.
• The vesting is contingent on continued service, meaning the RSUs could be forfeited if the director ceases to serve on the board before August 15, 2026.

Future Outlook

The Restricted Stock Units are scheduled to vest on August 15, 2026, contingent upon the reporting person's continued service on the board of directors.

Industry Context

Equity compensation, such as Restricted Stock Units, is a common practice across industries to attract, retain, and incentivize directors and executives by aligning their financial interests with long-term shareholder value. This grant is consistent with typical corporate governance practices for public companies.

Comparison to Industry Standards

• The grant of RSUs to a director is a standard practice for public companies, comparable to compensation structures at peers like Teladoc Health (TDOC) or Amwell (AMWL) in the telehealth sector, or other small-cap growth companies, where equity forms a significant part of executive and director compensation.
• The vesting schedule, tied to continued service, is a common mechanism to ensure long-term commitment, similar to practices observed in companies across various sectors.
• The specific number of units (112,781) would need to be benchmarked against Kindly MD's market capitalization and peer compensation levels to assess if it's within typical ranges, but the mechanism itself is standard.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with shareholder value creation, as the value of the RSUs depends on the company's stock performance. It also incentivizes long-term commitment from a board member.

Next Steps

• Eric Stanton Weiss is expected to continue his service on the board of directors until at least August 15, 2026.
• The 112,781 Restricted Stock Units are scheduled to vest on August 15, 2026.

Key Dates

Keywords

Kindly MD, NAKA, Eric Stanton Weiss, Director, Restricted Stock Units, RSU, Stock Grant, Beneficial Ownership, SEC Form 4, Equity Compensation, Corporate Governance